Assignee

Arcturus Therapeutics, Inc.

Patents = 59

Trademarks = 5

Forward Citations = 239

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

56 inventors (with patents filed for the assignee):

Arcturus Therapeutics is a leading clinical-stage mRNA medicines company focused on the discovery, development, and commercialization of therapeutics for rare diseases and vaccines. The company utilizes its proprietary LUNAR lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology platforms to develop a diverse range of RNA-based therapies. Arcturus' programs include treatments for liver diseases, cystic fibrosis, cardiovascular diseases, and COVID-19 vaccine development.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com